Phibro Animal Health (PAHC) Liabilities and Shareholders Equity (2013 - 2026)

Phibro Animal Health's Liabilities and Shareholders Equity history runs 14 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 9.71% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $5.6 billion (up 22.98% YoY), while the FY2025 annual figure was $1.4 billion, up 38.56% from the prior year.
• Liabilities and Shareholders Equity was $1.4 billion for Q1 2026 at Phibro Animal Health, up from $1.4 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.4 billion in Q1 2026 to a low of $916.2 million in Q1 2022.
• Historically, Liabilities and Shareholders Equity has averaged $1.1 billion across 5 years, with a median of $972.7 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity increased 0.18% in 2024, then soared 43.39% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $961.8 million in 2022, then advanced by 1.13% to $972.7 million in 2023, then soared by 32.16% to $1.3 billion in 2024, then gained by 9.34% to $1.4 billion in 2025, then advanced by 2.81% to $1.4 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $1.4 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.